DK0529568T3 - Nye oralt aktive elastaseinhibitorer - Google Patents

Nye oralt aktive elastaseinhibitorer

Info

Publication number
DK0529568T3
DK0529568T3 DK92114411.9T DK92114411T DK0529568T3 DK 0529568 T3 DK0529568 T3 DK 0529568T3 DK 92114411 T DK92114411 T DK 92114411T DK 0529568 T3 DK0529568 T3 DK 0529568T3
Authority
DK
Denmark
Prior art keywords
orally active
elastase inhibitors
active elastase
new orally
new
Prior art date
Application number
DK92114411.9T
Other languages
Danish (da)
English (en)
Inventor
Norton P Peet
Joseph P Burkhart
Michael R Angelastro
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0529568T3 publication Critical patent/DK0529568T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK92114411.9T 1991-08-22 1992-08-24 Nye oralt aktive elastaseinhibitorer DK0529568T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74860791A 1991-08-22 1991-08-22

Publications (1)

Publication Number Publication Date
DK0529568T3 true DK0529568T3 (da) 1997-02-03

Family

ID=25010166

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92114411.9T DK0529568T3 (da) 1991-08-22 1992-08-24 Nye oralt aktive elastaseinhibitorer

Country Status (16)

Country Link
EP (1) EP0529568B1 (fr)
JP (1) JP3311392B2 (fr)
KR (1) KR100242046B1 (fr)
AT (1) ATE147756T1 (fr)
AU (1) AU655831B2 (fr)
CA (1) CA2076307C (fr)
DE (1) DE69216713T2 (fr)
DK (1) DK0529568T3 (fr)
ES (1) ES2099186T3 (fr)
FI (1) FI923787A (fr)
GR (1) GR3022915T3 (fr)
HU (1) HU208703B (fr)
IL (1) IL102858A (fr)
NO (1) NO308999B1 (fr)
NZ (1) NZ243998A (fr)
ZA (1) ZA926185B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
NZ254503A (en) * 1992-07-29 1996-08-27 Merrell Dow Pharma Peptide pulmonary surfactants and compositions thereof
WO1994003484A1 (fr) * 1992-07-31 1994-02-17 Merrell Dow Pharmaceuticals Inc. Tensioactifs pulmonaires synthetiques a peptides, possedant des antioxydants lies de maniere covalente
US5977074A (en) * 1993-10-01 1999-11-02 Merrell Pharmaceuticals, Inc. Inhibitors of β-amyloid protein production
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (fr) * 1994-03-04 1995-09-05 Kenneth D. Kurz Agents antithrombotiques
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
CA2183428A1 (fr) * 1994-03-11 1995-09-14 John J. Baldwin Derives de sulfonamide et leur utilisation
EP0763055B1 (fr) * 1994-06-02 1999-11-03 Merrell Pharmaceuticals Inc. Inhibiteurs d'elastase au perfluoroalkyle cetone et procedes de production associes
DE69522940T2 (de) * 1994-06-02 2002-04-04 Merrell Pharma Inc Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
ATE246708T1 (de) * 1994-06-02 2003-08-15 Aventis Pharma Inc Elatase-inhibitoren
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US5691368A (en) * 1995-01-11 1997-11-25 Hoechst Marion Roussel, Inc. Substituted oxazolidine calpain and/or cathepsin B inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
KR100343553B1 (ko) * 1995-03-23 2002-10-31 에스케이케미칼주식회사 열가소성폴리에테르에스테르블록공중합체조성물
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
MXPA00011312A (es) * 1998-05-20 2003-04-22 Expression Genetics Inc Un vehiculo de gen polimerico de poli-l.lisina injertada con polietilenglicol con porcion de enfoque hepatocitos.
WO1999062538A1 (fr) 1998-06-03 1999-12-09 Cortech Inc. Alpha-ceto-oxadiazoles en tant qu'inhibiteurs de la serine protease
WO2013152170A1 (fr) 2012-04-04 2013-10-10 Catylix, Inc. Modulateurs sélectifs de récepteur d'androgène

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318318A1 (fr) * 1987-11-27 1989-05-31 Sensititre Limited Procédé d'essai d'urine et trousse
CA2077665A1 (fr) * 1990-03-05 1991-09-06 Robert Siman Proteases analogues a la chymotrypsine et leurs inhibiteurs
EP0480044A4 (en) * 1990-03-30 1993-06-09 Japan Tobacco Inc. Novel 4h-3,1-benzoxazin-4-one derivative

Also Published As

Publication number Publication date
AU655831B2 (en) 1995-01-12
IL102858A (en) 1998-12-27
JPH05213991A (ja) 1993-08-24
NO923280L (no) 1993-02-23
AU2106592A (en) 1993-02-25
CA2076307A1 (fr) 1993-02-23
ATE147756T1 (de) 1997-02-15
DE69216713T2 (de) 1997-05-28
FI923787A0 (fi) 1992-08-21
KR930004280A (ko) 1993-03-22
EP0529568A1 (fr) 1993-03-03
HU208703B (en) 1993-12-28
EP0529568B1 (fr) 1997-01-15
FI923787A (fi) 1993-02-23
GR3022915T3 (en) 1997-06-30
ZA926185B (en) 1993-03-01
CA2076307C (fr) 2003-01-07
ES2099186T3 (es) 1997-05-16
IL102858A0 (en) 1993-01-31
JP3311392B2 (ja) 2002-08-05
HUT62014A (en) 1993-03-29
NO923280D0 (no) 1992-08-21
NZ243998A (en) 1994-11-25
DE69216713D1 (de) 1997-02-27
KR100242046B1 (ko) 2000-03-02
NO308999B1 (no) 2000-11-27

Similar Documents

Publication Publication Date Title
DK0529568T3 (da) Nye oralt aktive elastaseinhibitorer
LV12209A (lv) Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori
NL300175I2 (nl) Methylsulfonylfenyl-2-(5H)-furanonen als remmers van COX-2.
ATE197043T1 (de) Pyrimidinyl-essigsäureamide als elastase inhibitoren
IL116078A (en) Substituted heterocyclic compounds capable of inhibiting serine proteases and pharmaceutical compositions containing them
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
DE60219887D1 (de) N-(3,-Dimethylindolin-6-yl)ä2-ä(4-pyridylmethyl)aminoü(3-pyridyl)ücarbonsäureamid und dieses enthaltende pharmazeutische Zubereitungen.
DE69314169T2 (de) Peptide mit eine alphaaminoboronaire gruppe and ihre verwendung als elastasehemmer
PT705100E (pt) Guanidinas substituidas terapeuticas
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
IS7616A (is) Frumuviðloðunarbælandi bólgueyðandi og ónæmisbælandi efnasambönd
NO934218L (no) Inhibitorer av cathepsin g og elastase for forhindring av bindevevsned-brytning
DE69126460T2 (de) Benzisothiazolinon-1-dioxyde als Elastase-Inhibitoren
NO944946L (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
ATE253571T1 (de) 2-heterozyklisch-5-hydroxy-1,3-pyrimidinen verwendbar als entzündungswidrigesmittel
DE69715173T2 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
ATE105302T1 (de) Fluoramid-derivate mit hemmender aktivitaet gegen menschliche leukozytenelastase.
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
BR9510257A (pt) Monômeros ciclohexan-1-óis 4,4-(di-substituidos) e compostos relacionados
NO945091L (no) Fluorholdige dipeptider som inhibitorer mot menneske-leukocyt-elastase-inhibitorer
ITMI911930A1 (it) Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico.